Clinical outcome of three fractionation schedules of preoperative radiotherapy for rectal cancer

被引:0
|
作者
Wzietek, Iwona [1 ,2 ]
Wydmanski, Jerzy [1 ,2 ]
Suwinski, Rafal [1 ,2 ]
机构
[1] Maria Sklodowska Curie Mem Canc Ctr, Dept Radiat Oncol, Wybrzeze AK 15, PL-44101 Gliwice, Poland
[2] Inst Oncol, Gliwice Branch, Gliwice, Poland
关键词
preoperative radiotherapy; rectal cancer; fractionation;
D O I
10.1016/S1507-1367(10)60004-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
AIM: To evaluate the effectiveness and normal tissue reactions of three fractionation schedules of preoperative radiotherapy for locally advanced rectal cancer. MATERIALS AND METHODS: Between 1996 and 2002, 168 patients with locally advanced rectal cancer were treated as follows: 53 patients received 25 Gy in 5 Gy per fraction (group A), 45 received 30 Gy in 3.0 Gy per fraction (group B), and 70 were treated with accelerated hyperfractionation: 42 Gy, 1.5 Gy per fraction, given twice a day with an inter-fraction interval of 6 hours (group C). The clinical characteristics of the groups were comparable. The patients did not receive concurrent chemotherapy. A Cox proportional hazard regression model was used to analyze the factors which may influence loco-regional tumour control (LRC) and overall survival (OS). RESULTS: The following variables significantly influenced LRC: fractionation scheme (5-year LRC 80%, 69%, and 90% in groups A, B, C respectively, p=0.016), haemoglobin concentration before radiotherapy (p=0.012) and postoperative chemotherapy (p=0.01). Age, sex, stage of disease, location of tumour (distance of the tumour from the anal verge) and performance status did not appear significant for LRC. The overall 5-year OS was 64%, 59% and 74% in groups A, B, C respectively (p=0.056). The OS was significantly influenced by postoperative pathological stage (p=0.006), tumour location (p=0.015) and postoperative chemotherapy (p=0.047). The most frequent acute radiation reaction was mild/severe diarrhoea, which appeared in 5%, 21.6% and 65.5% of the patients from groups A-C respectively. The median wound healing time in those who underwent abdomino-perineal resections was 6, 6 and 4 weeks. Other reactions appeared less relevant. There was no significant difference in the incidence of late effects among the three treatment groups. CONCLUSION: While due to the non-randomized character of the study the conclusions should be regarded as hypothesis-generating only, the analysis has shown an acceptable local effectiveness and tolerance of schedules A and C, and disappointing effectiveness of schedule B. The present study thus supports the data which suggest that the clinical effect of preoperative radiotherapy for rectal cancer is influenced not only by total radiation dose but also by overall radiation treatment time and dose per fraction.
引用
收藏
页码:135 / 143
页数:9
相关论文
共 50 条
  • [1] Moderately low alpha/beta ratio for rectal cancer may best explain the outcome of three fractionation schedules of preoperative radiotherapy
    Suwinski, Rafal
    Wzietek, Iwona
    Tarnawski, Rafal
    Namysl-Kaletka, Agnieszka
    Kryj, Mariusz
    Chmielarz, Andrzej
    Wydmanski, Jerzy
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : 793 - 799
  • [2] Dose-time fractionation schedules of preoperative radiotherapy and timing to surgery for rectal cancer
    Jin, Fu
    Luo, Huanli
    Zhou, Juan
    Wu, Yongzhong
    Sun, Hao
    Liu, Hongliang
    Zheng, Xiaodong
    Wang, Ying
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [3] Preoperative Radiotherapy of Rectal Cancer-Influence of Fractionation and Dose
    Kubecova, M.
    Korinek, P.
    Sejdova, M.
    Ambrus, M.
    HEPATO-GASTROENTEROLOGY, 2010, 57 (98) : 246 - 250
  • [4] Preoperative Radiotherapy Improves Outcome in Recurrent Rectal Cancer
    Vermaas, Maarten
    Ferenschild, Floris T. J.
    Nuyttens, Joost J. M. E.
    Marinelli, Andreas W. K. S.
    Wiggers, Theo
    van der Sijp, Joost R. M. M.
    Verhoef, Cornelis
    Graveland, Wilfried J.
    Eggermont, Alexander M. M.
    de Wilt, Johannes H. W.
    COLOPROCTOLOGY, 2006, 28 (02) : 85 - 96
  • [5] Preoperative radiotherapy improves outcome in recurrent rectal cancer
    Vermaas, M
    Ferenschild, FTJ
    Nuyttens, JJME
    Marinelli, AWKS
    Wiggers, T
    van der Sijp, JRMM
    Verhoef, C
    Graveland, WJ
    Eggermont, AMM
    de Wilt, JHW
    DISEASES OF THE COLON & RECTUM, 2005, 48 (05) : 918 - 928
  • [6] Clinical outcome in 520 consecutive Danish rectal cancer patients treated with short course preoperative radiotherapy
    Jensen, L. H.
    Altaf, R.
    Harling, H.
    Jensen, M.
    Laurberg, S.
    Lindegaard, J. C.
    Muhic, A.
    Vestermark, L.
    Jakobsen, A.
    Bulow, S.
    EJSO, 2010, 36 (03): : 237 - 243
  • [7] Endosonographic Assessment of the Response of Rectal Cancer to Preoperative Radiotherapy Endosonographic Assessment of the Response of Rectal Cancer to Preoperative Radiotherapy
    Tankova, Ludmila
    Hadjieva, Tatyana
    Kovatchki, Daniel
    Damianov, Nikolay
    HEPATO-GASTROENTEROLOGY, 2009, 56 (96) : 1645 - 1650
  • [8] Preoperative versus Postoperative Radiotherapy for Rectal Cancer in a Decision Analysis and Outcome Prediction Model
    Andreas M. Kaiser
    Daniel Klaristenfeld
    Robert W. Beart
    Annals of Surgical Oncology, 2012, 19 : 4150 - 4160
  • [9] Preoperative radiotherapy for rectal cancer: beyond local control
    Allal, AS
    Soravia, C
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (03): : 124 - 125
  • [10] Preoperative concurrent chemotherapy and radiotherapy in rectal cancer patients
    Ch'ang, HJ
    Jian, JJM
    Cheng, SH
    Liu, MC
    Leu, SY
    Wang, FM
    Tsai, SYC
    Tsao, MH
    Lin, HH
    Huang, AT
    Sung, JL
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1998, 97 (01) : 32 - 37